2
|
Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic Vessel Network Structure and Physiology. Compr Physiol 2018; 9:207-299. [PMID: 30549020 DOI: 10.1002/cphy.c180015] [Citation(s) in RCA: 168] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The lymphatic system is comprised of a network of vessels interrelated with lymphoid tissue, which has the holistic function to maintain the local physiologic environment for every cell in all tissues of the body. The lymphatic system maintains extracellular fluid homeostasis favorable for optimal tissue function, removing substances that arise due to metabolism or cell death, and optimizing immunity against bacteria, viruses, parasites, and other antigens. This article provides a comprehensive review of important findings over the past century along with recent advances in the understanding of the anatomy and physiology of lymphatic vessels, including tissue/organ specificity, development, mechanisms of lymph formation and transport, lymphangiogenesis, and the roles of lymphatics in disease. © 2019 American Physiological Society. Compr Physiol 9:207-299, 2019.
Collapse
Affiliation(s)
- Jerome W Breslin
- Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA
| | - Ying Yang
- Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA
| | - Joshua P Scallan
- Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA
| | - Richard S Sweat
- Department of Biomedical Engineering, Tulane University, New Orleans, Tampa, Louisiana, USA
| | - Shaquria P Adderley
- Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA
| | - Walter L Murfee
- Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA
| |
Collapse
|
6
|
Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20:672-82. [PMID: 11179212 PMCID: PMC145430 DOI: 10.1093/emboj/20.4.672] [Citation(s) in RCA: 698] [Impact Index Per Article: 30.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
Metastasis is a frequent and lethal complication of cancer. Vascular endothelial growth factor-C (VEGF-C) is a recently described lymphangiogenic factor. Increased expression of VEGF-C in primary tumours correlates with dissemination of tumour cells to regional lymph nodes. However, a direct role for VEGF-C in tumour lymphangiogenesis and subsequent metastasis has yet to be demonstrated. Here we report the establishment of transgenic mice in which VEGF-C expression, driven by the rat insulin promoter (Rip), is targeted to beta-cells of the endocrine pancreas. In contrast to wild-type mice, which lack peri-insular lymphatics, RipVEGF-C transgenics develop an extensive network of lymphatics around the islets of Langerhans. These mice were crossed with Rip1Tag2 mice, which develop pancreatic beta-cell tumours that are neither lymphangiogenic nor metastatic. Double-transgenic mice formed tumours surrounded by well developed lymphatics, which frequently contained tumour cell masses of beta-cell origin. These mice frequently developed pancreatic lymph node metastases. Our findings demonstrate that VEGF-C-induced lymphangiogenesis mediates tumour cell dissemination and the formation of lymph node metastases.
Collapse
Affiliation(s)
- Stefano J. Mandriota
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | - Lotta Jussila
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | - Michael Jeltsch
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | - Amelia Compagni
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | | | - Remko Prevo
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | - Suneale Banerji
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | | | | | - David G. Jackson
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | | | - Kari Alitalo
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | - Gerhard Christofori
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| | - Michael S. Pepper
- Department of Morphology, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland,
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Finland, Institute of Molecular Pathology, Vienna, Austria and MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK Present address: The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK Corresponding author e-mail:
| |
Collapse
|